Overview

Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis

Status:
Completed
Trial end date:
2010-09-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoarthritis of the knee.
Phase:
Phase 3
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Nordic Bioscience A/S
Collaborator:
Novartis
Treatments:
Calcitonin
Calcitonin Gene-Related Peptide
Katacalcin
Salmon calcitonin
Criteria
Inclusion Criteria:

- Medical history and symptoms of knee osteoarthritis

Exclusion Criteria:

- Any other disease or medication affecting the bone or cartilage.

- Any clinical signs or laboratory evidence diseases, which in the Investigator's
opinion would preclude the participant from adhering to the Protocol or completing the
trial.

Other protocol defined inclusion/exclusion criteria may apply